Cargando…

M(pro)pred: A machine learning (ML) driven Web-App for bioactivity prediction of SARS-CoV-2 main protease (M(pro)) antagonists

The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic emerged in 2019 and still requiring treatments with fast clinical translatability. Frequent occurrence of mutations in spike glycoprotein of SARS-CoV-2 led the consideration of an alternative therapeutic target to combat the o...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ferdous, Nadim, Reza, Mahjerin Nasrin, Hossain, Mohammad Uzzal, Mahmud, Shahin, Napis, Suhami, Chowdhury, Kamal, Mohiuddin, A. K. M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2023
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10289339/ https://www.ncbi.nlm.nih.gov/pubmed/37352252 http://dx.doi.org/10.1371/journal.pone.0287179

Ejemplares similares

Molecular characterization and functional annotation of a hypothetical protein (SCO0618) of Streptomyces coelicolor A3(2)
por: Ferdous, Nadim, et al.
Publicado: (2020)

Pathogenic genetic variants from highly connected cancer susceptibility genes confer the loss of structural stability
por: Reza, Mahjerin Nasrin, et al.
Publicado: (2021)

Newly designed analogues from SARS-CoV inhibitors mimicking the druggable properties against SARS-CoV-2 and its novel variants
por: Ferdous, Nadim, et al.
Publicado: (2021)

Pathogen-driven gene expression patterns lead to a novel approach to the identification of common therapeutic targets
por: Hossain, Mohammad Uzzal, et al.
Publicado: (2022)

Diphenyl Diselenide and SARS-CoV-2: in silico Exploration of the Mechanisms of Inhibition of Main Protease (M(pro)) and Papain-like Protease (PL(pro))
por: Omage, Folorunsho Bright, et al.
Publicado: (2023)

In silico analysis of echinocandins binding to the main proteases of coronaviruses PEDV (3CL(pro)) and SARS-CoV-2 (M(pro))
por: Vergoten, Gérard, et al.
Publicado: (2021)

Expression, purification, and biophysical characterization of recombinant MERS-CoV main (M(pro)) protease
por: Almutairi, Ghada Obeid, et al.
Publicado: (2022)

The temperature-dependent conformational ensemble of SARS-CoV-2 main protease (M(pro))
por: Ebrahim, Ali, et al.
Publicado: (2021)

Review on development of potential inhibitors of SARS-CoV-2 main protease (M(Pro))
por: Katre, Soumya Gulab, et al.
Publicado: (2022)

In silico analysis of selected alkaloids against main protease (M(pro)) of SARS-CoV-2
por: Garg, Saksham, et al.
Publicado: (2020)

Microbial Natural Products as Potential Inhibitors of SARS-CoV-2 Main Protease (M(pro))
por: Sayed, Ahmed M., et al.
Publicado: (2020)

In silico approach for identification of natural compounds as potential COVID 19 main protease (M(pro)) inhibitors
por: Chaturvedi, Monika, et al.
Publicado: (2021)

In silico investigation of saponins and tannins as potential inhibitors of SARS-CoV-2 main protease (M(pro))
por: Falade, Victoria Adeola, et al.
Publicado: (2021)

Drug repurposing and computational modeling for discovery of inhibitors of the main protease (M(pro)) of SARS-CoV-2
por: Silva, José Rogério A., et al.
Publicado: (2021)

The temperature-dependent conformational ensemble of SARS-CoV-2 main protease (M(pro))
por: Ebrahim, Ali, et al.
Publicado: (2022)

The SARS‐CoV‐2 main protease (M(pro)): Structure, function, and emerging therapies for COVID‐19
por: Hu, Qing, et al.
Publicado: (2022)

Autochthonous Peruvian Natural Plants as Potential SARS-CoV-2 M(pro) Main Protease Inhibitors
por: Peralta-Moreno, Maria Nuria, et al.
Publicado: (2023)

Protegrin-2, a potential inhibitor for targeting SARS-CoV-2 main protease M(pro)
por: Jan, Zainab, et al.
Publicado: (2023)

Designing of improved drugs for COVID-19: Crystal structure of SARS-CoV-2 main protease M(pro)
por: Mengist, Hylemariam Mihiretie, et al.
Publicado: (2020)

Are vanadium complexes druggable against the main protease M(pro) of SARS-CoV-2? – A computational approach
por: Scior, Thomas, et al.
Publicado: (2021)

Computational investigation of natural compounds as potential main protease (M(pro)) inhibitors for SARS-CoV-2 virus
por: Patel, Chirag N., et al.
Publicado: (2022)

Crystal structures of main protease (M(pro)) mutants of SARS-CoV-2 variants bound to PF-07304814
por: Jiang, Haihai, et al.
Publicado: (2023)

In Silico Substrate-Binding Profiling for SARS-CoV-2 Main Protease (M(pro)) Using Hexapeptide Substrates
por: Zabo, Sophakama, et al.
Publicado: (2023)

Structure and Dynamics of Sars Coronavirus Main Proteinase (M(PRO))
por: Hilgenfeld, Rolf, et al.
Publicado: (2006)

Amentoflavone derivatives significantly act towards the main protease (3CL(PRO)/M(PRO)) of SARS-CoV-2: in silico admet profiling, molecular docking, molecular dynamics simulation, network pharmacology
por: Dey, Dipta, et al.
Publicado: (2022)

Targeting novel structural and functional features of coronavirus protease nsp5 (3CL(pro), M(pro)) in the age of COVID-19
por: Roe, Molly K., et al.
Publicado: (2021)

FlipGFP protease assay for evaluating in vitro inhibitory activity against SARS-CoV-2 M(pro) and PL(pro)
por: Tan, Haozhou, et al.
Publicado: (2023)

70ProPred: a predictor for discovering sigma70 promoters based on combining multiple features
por: He, Wenying, et al.
Publicado: (2018)

Prediction of Novel Inhibitors of the Main Protease (M-pro) of SARS-CoV-2 through Consensus Docking and Drug Reposition
por: Gimeno, Aleix, et al.
Publicado: (2020)

Exploration of inhibitory action of Azo imidazole derivatives against COVID-19 main protease (M(pro)): A computational study
por: Chhetri, Abhijit, et al.
Publicado: (2021)

In Silico Mining of Terpenes from Red-Sea Invertebrates for SARS-CoV-2 Main Protease (M(pro)) Inhibitors
por: Ibrahim, Mahmoud A. A., et al.
Publicado: (2021)

Synthesis of New Binary Thiazole-Based Heterocycles and Their Molecular Docking Study as COVID-19 Main Protease (M(pro)) Inhibitors
por: Abdel-Latif, E., et al.
Publicado: (2021)

Quantum simulations of SARS-CoV-2 main protease M(pro) enable high-quality scoring of diverse ligands
por: Wang, Yuhang, et al.
Publicado: (2021)

Inhibitory effects of selected isoquinoline alkaloids against main protease (M(pro)) of SARS-CoV-2, in silico study
por: Sadeghi, Morteza, et al.
Publicado: (2022)

Discovery of novel SARS-CoV-2 inhibitors targeting the main protease M(pro) by virtual screenings and hit optimization
por: Mercorelli, Beatrice, et al.
Publicado: (2022)

In vitro and in silico studies of SARS-CoV-2 main protease M(pro) inhibitors isolated from Helichrysum bracteatum
por: Wahab, Gehad Abdel, et al.
Publicado: (2022)

Theaflavin 3-gallate inhibits the main protease (M(pro)) of SARS-CoV-2 and reduces its count in vitro
por: Chauhan, Mahima, et al.
Publicado: (2022)

Allosteric Modulation of the Main Protease (M(Pro)) of SARS-CoV-2 by Casticin—Insights from Molecular Dynamics Simulations
por: Mensah, Jehoshaphat Oppong, et al.
Publicado: (2022)

Molecular Dynamics Simulation of Ligands from Anredera cordifolia (Binahong) to the Main Protease (M(pro)) of SARS-CoV-2
por: Fatriansyah, Jaka Fajar, et al.
Publicado: (2022)

A Tale of Two Proteases: M(Pro) and TMPRSS2 as Targets for COVID-19 Therapies
por: Farkaš, Barbara, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_b26b958hukdqa7lpv5ttcjfa3t